Cytokine release syndrome.

Shimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, Schlößer HA, Schlaak M, Kochanek M, Böll B, von Bergwelt-Baildon MS. · 2018

Read Cytokine release syndrome. by Shimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, Schlößer HA, Schlaak M, Kochanek M, Böll B, von Bergwelt-Baildon MS. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6003181.txt.

Description

Shimabukuro-Vornhagen and co-authors review cytokine release syndrome, a dangerous side effect of modern cancer immunotherapy. Their review appeared in the Journal for Immunotherapy of Cancer. Potent new treatments have transformed cancer care this decade. Checkpoint drugs and engineered T cells work remarkably well. Yet they can trigger a whole-body inflammatory storm. That storm can prove fatal if missed. The term dates to an early anti-T-cell antibody drug.

The review covers how the syndrome develops mechanistically. Risk factors, symptoms, and look-alike conditions are laid out. Prognostic signs that warn of severe courses are covered. Practical guidance for managing patients follows the evidence.

Catalog record

CREATORShimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, Schlößer HA, Schlaak M, Kochanek M, Böll B, von Bergwelt-Baildon MS.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE59 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6003181

Browse the full library · About the Tower of Babel